Investor Presentaiton

Regulation of Gene Therapy Products and its Approval Research and Development Non-(pre-) clinical Study Pre-IND to MHLW IND to PMDA Clinical Trial New drug application Approval as a New Drug Assessment of Adverse Effect on Biological Diversity (viral vectors) Guidelines for assuring the Quality and Safety of gene therapy products

View entire presentation